国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Global EditionASIA 中文雙語(yǔ)Fran?ais
China
Home / China / Health

Surgical technique developed in China helps thousands abroad

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2025-10-06 17:50
Share
Share - WeChat

A domestically-developed, novel surgical method for a common heart disease has been used to treat over 200,000 patients in more than 60 countries and regions, and has the potential to reach even more in underserved and remote areas across the globe, a senior cardiologist said recently.

The percutaneous and non-fluoroscopy (PAN) procedure offers a simplified approach to mitral valve transcatheter edge-to-edge repair. This treatment addresses mitral valve regurgitation, a disorder where the heart valve fails to close properly during pumping, causing blood to leak backward.

Developed by Pan Xiangbin, vice-president of Fuwai Hospital of the Chinese Academy of Medical Sciences & Peking Union Medical College, and his team, the PAN procedure primarily features the use of ultrasound guidance instead of X-rays, eliminating the risk of harmful radiation exposure.

With support from the United Nations Peace and Development Fund, the procedure is being promoted in developing countries, aiming to improve impoverished patients' access to quality cardiovascular care, while reducing their financial burdens.

The Chinese team has also developed mobile surgical vehicles to offer door-to-door procedures, making medical services more easily accessible, Xie Yongquan, deputy director of the hospital's department of structural heart disease, said during the 2025 China Heart Congress that was held in Beijing in late September.

Xie added that an international standard for the PAN procedure, formulated by the Chinese team, has been made permanently open and free by the IEEE Standards Association, enabling remote and less-developed regions to adopt this advanced medical solution.

Large-scale, multicenter clinical trials will also generate robust evidence to solidify the treatment's position in standard clinical care, according to Xie.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
凤冈县| 凤阳县| 莎车县| 乳源| 宁南县| 都昌县| 阳曲县| 水富县| 光山县| 迁安市| 林州市| 内丘县| 桓台县| 镇赉县| 渝北区| 大同市| 重庆市| 邢台县| 宜丰县| 息烽县| 昌黎县| 长岭县| 自贡市| 翼城县| 上饶市| 蒙自县| 科技| 托克托县| 南乐县| 永兴县| 台南市| 连山| 赤城县| 永济市| 上杭县| 乐平市| 保康县| 兴业县| 陇川县| 平昌县| 罗江县|